Researchers have identified brain-derived tau as a blood biomarker that tracks brain injury progression after ischemic stroke and predicts long-term outcomes, according to a study of over 1,200 patients published in Science Translational Medicine.
NanoDx, Inc., has entered into a licensing agreement with IBM Research for use of its nanoscale sensors for accurate, rapid testing.
Performed on the company’s newest analyzer, the Vitros XT 7600 integrated system, the High-Sensitivity Troponin I assay aids in diagnosing heart attacks faster and more accurately.
This month’s issue features medical-grade refrigerators from Follett, disposable pipette tips from Tecan, and a microscope camera from Zeiss.
Read More
Quest Diagnostics has approved a definitive agreement to acquire Cleveland HeartLab, with the intent of establishing a national center of excellence in heart disease diagnostic information services.
Read More
A scientific statement from the American Heart Association determines that the Corus CAD blood test is useful in diagnosing suspected coronary artery disease.
Read More
Quest Diagnostics will begin providing nonfasting cholesterol tests designed to improve the assessment of heart disease risk.
Read More
This month’s issue features a molecular diagnostics system from XimedicaDx, a clinical chemistry analyzer from Randox Laboratories, and a sorting instrument from Yaskawa Motoman.
Read More
The device blends enhanced slow-flow rates with precision dispensing for increased application flexibility across a wide volume range.
Read MoreClinicians are using pharmacogenomic testing to identify gene-drug interactions to guide precise patient therapies.
Read MoreDavid A. Ahlquist, MD, coinventor of the Cologuard stool-based DNA screening test for colorectal cancer, discusses updated USPSTF guidelines that seek to increase screening rates.
Read MoreThe number of people living with diabetes and its prevalence are growing in all regions of the world.
Read MoreCandidates have demonstrated comparable preclinical efficacy to existing anticoagulants but with substantially lower bleeding liability.
Read More
Current and emerging cardiac markers are signaling improved testing for better patient outcomes.
Read More
The conclusion to our three-part series exploring the value of diagnostics.
Read More
The DiscoveryMap platform from Myriad RBM has identified combinations of 15 protein biomarkers associated with cardiovascular events in patients with diabetes.
Read More
Lab professionals can expect that flow cytometry will continue to evolve in new directions with even greater utility for clinical testing.
Read More
The biennial ASCP vacancy survey has captured a profession in transition.
Read More